Clinical Trials Directory

Trials / Completed

CompletedNCT03754231

Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
KK Women's and Children's Hospital · Other Government
Sex
All
Age
3 Years – 17 Years
Healthy volunteers
Not accepted

Summary

This proposal describes the evaluation of a CE-marked, FDA cleared vital signs Surveillance Monitoring system in a paediatric outpatient population in KK Women's and Children's Hospital ("KKH"), the main tertiary women and children hospital in Singapore. User acceptance of Aingeal and the Surveillance System will be considered within the clinical settings.

Detailed description

RENEW's Surveillance Monitoring system is made up of two main components: a patient-worn wireless vital signs monitor (Aingeal) that transmits data over Wi-Fi to a central station software platform (Surveillance Station). The Aingeal device measures single lead ECG, heart rate, respiration waveform and rate, and skin temperature. A snapshot of data is transmitted by the devices intermittently to the Surveillance Station, enabling vital signs trends to be plotted. This proposal describes the evaluation of RENEW's Aingeal device in a paediatric outpatient population in KK Women's and Children's Hospital ("KKH"), the main tertiary women and children hospital in Singapore. In the paediatric population, assessment of RENEW's Aingeal device will include the accuracy of the device at deriving heart rate from single lead ECG and at deriving respiratory rate when compared against a commonly used vital signs monitor. User acceptance of Aingeal and the Surveillance System will be considered within the clinical settings.

Conditions

Interventions

TypeNameDescription
OTHERHeart rate monitoringThe heart rate of recruited patients will be monitored for 15 minutes over 2 phases: i) 10 minutes at rest ii) 5 minutes during physical activity in the form of walking or playing
OTHERRespiratory rate monitoringThe heart rate of recruited patients will be monitored for 15 minutes over 2 phases: i) 10 minutes at rest ii) 5 minutes during physical activity in the form of walking or playing

Timeline

Start date
2018-01-30
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2018-11-27
Last updated
2022-03-31

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT03754231. Inclusion in this directory is not an endorsement.